With Cash balance at end of quarter $14.4M (vs $14.3M as at 31 December, 2016)
AND Quarterly sales of $4.9M taking revenue for first 9 months to $17.2M, up 70% on the prior corresponding period (PCP) and on track to meet annual forecast
I would not be worried about the HSV-2, if it is good then it will be a huge + for SP if not then i do not think it will affect a lot on SP as you can see that the MC is too low and matket have never cared or included these vax programs into MC
- Forums
- ASX - By Stock
- AVR
- Ann: HSV-2 Phase IIa Results Investor Webinar
Ann: HSV-2 Phase IIa Results Investor Webinar, page-13
-
- There are more pages in this discussion • 284 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$13.70 |
Change
-0.300(2.14%) |
Mkt cap ! $295.9M |
Open | High | Low | Value | Volume |
$14.05 | $14.05 | $13.70 | $73.96K | 5.356K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7 | $13.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.69 | 241 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7 | 13.300 |
1 | 250 | 13.150 |
1 | 500 | 13.110 |
1 | 70 | 13.100 |
1 | 25 | 13.070 |
Price($) | Vol. | No. |
---|---|---|
13.690 | 241 | 2 |
13.700 | 623 | 1 |
13.770 | 281 | 3 |
13.900 | 1000 | 1 |
14.000 | 1278 | 4 |
Last trade - 12.54pm 08/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |